Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: Updated results from the randomized multicenter GLARIUS trial

Herrlinger, U. and Schaefer, N. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Kohnen, R. and Urbach, H. and Stummer, W. and Glas, M. (2013) Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: Updated results from the randomized multicenter GLARIUS trial. EUROPEAN JOURNAL OF CANCER, 49 (Suppl2). S774. ISSN 0959-8049, 1879-0852

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 18 Jun 2020 09:22
Last Modified: 18 Jun 2020 09:22
URI: https://pred.uni-regensburg.de/id/eprint/16090

Actions (login required)

View Item View Item